Literature DB >> 29589265

ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations-comment.

Leonardo Campiotti1,2, Matteo Basilio Sutter3, Elena Bolzacchini3, Alessandro Squizzato4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29589265     DOI： 10.1007/s11739-018-1838-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  Optimizing tolerability of TKI therapy in CML.

Authors:  Andreas Hochhaus
Journal:  Blood       Date:  2014-02-27       Impact factor: 22.113

2.  ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations.

Authors:  Emanuel Raschi; Igor Diemberger; Benilde Cosmi; Fabrizio De Ponti
Journal:  Intern Emerg Med       Date:  2017-09-23       Impact factor: 3.397

Review 3.  Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis.

Authors:  Leonardo Campiotti; Matteo Basilio Suter; Luigina Guasti; Rocco Piazza; Carlo Gambacorti-Passerini; Anna Maria Grandi; Alessandro Squizzato
Journal:  Eur J Cancer       Date:  2017-03-30       Impact factor: 9.162

4.  Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial.

Authors:  Jeffrey H Lipton; Charles Chuah; Agnès Guerci-Bresler; Gianantonio Rosti; David Simpson; Sarit Assouline; Gabriel Etienne; Franck E Nicolini; Philipp le Coutre; Richard E Clark; Leif Stenke; David Andorsky; Vivian Oehler; Stephanie Lustgarten; Victor M Rivera; Timothy Clackson; Frank G Haluska; Michele Baccarani; Jorge E Cortes; François Guilhot; Andreas Hochhaus; Timothy Hughes; Hagop M Kantarjian; Neil P Shah; Moshe Talpaz; Michael W Deininger
Journal:  Lancet Oncol       Date:  2016-04-12       Impact factor: 41.316

5.  A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

Authors:  J E Cortes; D-W Kim; J Pinilla-Ibarz; P le Coutre; R Paquette; C Chuah; F E Nicolini; J F Apperley; H J Khoury; M Talpaz; J DiPersio; D J DeAngelo; E Abruzzese; D Rea; M Baccarani; M C Müller; C Gambacorti-Passerini; S Wong; S Lustgarten; V M Rivera; T Clackson; C D Turner; F G Haluska; F Guilhot; M W Deininger; A Hochhaus; T Hughes; J M Goldman; N P Shah; H Kantarjian
Journal:  N Engl J Med       Date:  2013-11-01       Impact factor: 91.245
  5 in total
  1 in total

1.  ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations-authors' reply.

Authors:  Emanuel Raschi; Igor Diemberger; Benilde Cosmi; Fabrizio De Ponti
Journal:  Intern Emerg Med       Date:  2018-04-25       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.